| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Common Stock | Options Exercise | $0 | +3,333 | +2.5% | $0.000000 | 137,894 | 17 Feb 2022 | Direct | F1 |
| transaction | BSX | Common Stock | Tax liability | $43,687 | -1,020 | -0.74% | $42.83 | 136,874 | 17 Feb 2022 | Direct | |
| transaction | BSX | Common Stock | Options Exercise | $0 | +2,816 | +2.1% | $0.000000 | 139,690 | 18 Feb 2022 | Direct | F2 |
| transaction | BSX | Common Stock | Tax liability | $36,678 | -862 | -0.62% | $42.55 | 138,828 | 18 Feb 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Restricted Stock Units | Options Exercise | $0 | -3,333 | -25% | $0.000000 | 10,000 | 17 Feb 2022 | Common Stock | 3,333 | Direct | F1, F3 | |
| transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -2,816 | -33% | $0.000000 | 5,634 | 18 Feb 2022 | Common Stock | 2,816 | Direct | F2, F4 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| F2 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| F3 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant. |
| F4 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant. |